Astbury Centre for Structural Molecular Biology and School of Molecular & Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
Department of Molecular Biology, Umeå University, 90187 Umeå, Sweden.
Nucleic Acids Res. 2022 Feb 28;50(4):2128-2142. doi: 10.1093/nar/gkac058.
The first member of the pleuromutilin (PLM) class suitable for systemic antibacterial chemotherapy in humans recently entered clinical use, underscoring the need to better understand mechanisms of PLM resistance in disease-causing bacterial genera. Of the proteins reported to mediate PLM resistance in staphylococci, the least-well studied to date is Sal(A), a putative ABC-F NTPase that-by analogy to other proteins of this type-may act to protect the ribosome from PLMs. Here, we establish the importance of Sal proteins as a common source of PLM resistance across multiple species of staphylococci. Sal(A) is revealed as but one member of a larger group of Sal-type ABC-F proteins that vary considerably in their ability to mediate resistance to PLMs and other antibiotics. We find that specific sal genes are intrinsic to particular staphylococcal species, and show that this gene family is likely ancestral to the genus Staphylococcus. Finally, we solve the cryo-EM structure of a representative Sal-type protein (Sal(B)) in complex with the staphylococcal 70S ribosome, revealing that Sal-type proteins bind into the E site to mediate target protection, likely by displacing PLMs and other antibiotics via an allosteric mechanism.
最近,第一个适合人类全身抗菌化疗的截短侧耳素 (PLM) 类药物进入临床使用,这突显了需要更好地了解致病细菌属中 PLM 耐药机制的必要性。在报告的介导葡萄球菌中 PLM 耐药的蛋白中,迄今为止研究最少的是 Sal(A),一种假定的 ABC-F NTPase,通过类比该类型的其他蛋白,它可能起到保护核糖体免受 PLM 侵害的作用。在这里,我们确定了 Sal 蛋白作为多种葡萄球菌中常见的 PLM 耐药来源的重要性。Sal(A) 只是更大的 Sal 型 ABC-F 蛋白组的一个成员,该蛋白组在介导对 PLM 和其他抗生素的耐药性方面差异很大。我们发现,特定的 sal 基因是特定葡萄球菌物种所固有的,并且表明该基因家族可能是葡萄球菌属的祖先。最后,我们解决了代表 Sal 型蛋白 (Sal(B)) 与葡萄球菌 70S 核糖体复合物的低温电镜结构,揭示了 Sal 型蛋白结合到 E 位以介导靶标保护,可能通过别构机制置换 PLM 和其他抗生素。